Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from MicroPort CardioFlow Medtech Corp. ( (HK:2160) ).
MicroPort CardioFlow Medtech Corporation has called an extraordinary general meeting for 11 February 2026 to seek shareholder approval for a share consolidation, under which every five existing issued and unissued shares with a par value of US$0.000005 will be consolidated into one share with a par value of US$0.000025. The company has also announced the closure of its register of members from 6 to 11 February 2026 to determine entitlements to attend and vote at the meeting, a procedural step that may affect liquidity in the short term but is aimed at restructuring the share capital, which could influence the stock’s trading profile and appeal to certain institutional investors.
The most recent analyst rating on (HK:2160) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on MicroPort CardioFlow Medtech Corp. stock, see the HK:2160 Stock Forecast page.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corporation is a Hong Kong-listed medical technology company focused on cardiovascular interventions. It develops and markets transcatheter and other minimally invasive cardiac therapies, targeting patients with structural heart diseases and related cardiovascular conditions in China and international markets.
Average Trading Volume: 4,775,329
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.81B
See more insights into 2160 stock on TipRanks’ Stock Analysis page.